METTL3 and osteosarcoma: Specifically, METTL3-catalyzed m6A modification augments TGF-β1 transcript stability and translational efficiency by facilitating post-transcriptional mRNA processing, leading to increased secretion of TGF-β1 by osteosarcoma cells.